ACADIA Share Price

ACADIA Share Price

NASDAQ: ACAD | Mid Cap | Healthcare
$17.10
-$0.47 (-2.68%) Last updated on 21 Nov, 2026 | 02:30 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

ACADIA Stock Performance

Open
$17.47
Prev. Close
$17.57
Circuit Range
N/A
Day Range
$17.06 - $17.76
Year Range
$15.86 - $30.93
Volume
1,17,174
Average Traded
$17.35

ACADIA Share Price Today

As of 21 November 2026, ACADIA Pharmaceuticals Inc.'s share price is $17.10. The stock opened at $17.47, compared to its previous close of $17.57. During today's trading session, ACADIA Pharmaceuticals Inc.'s share price traded between $17.06 and $17.76, with an average price of $17.41. Over the past 52 weeks, the stock has recorded a high of $30.93 and a low of $15.86. In terms of performance, ACADIA Pharmaceuticals Inc.'s share price has declined by 21.05% over the last six months and is down 31.65% on a year-on-year basis.

ACADIA Share Price Chart

Line chart of the ACADIA price trend over the selected period. The price fell overall, ranging from 17.09 to 17.76, ending at 17.11.
$17.06$17.76
L
Show Current Price
H

ACADIA Stock Fundamentals & Key Indicators

Market Cap
$2.88B
PE Ratio (TTM)
8.16
Dividend Yield
0.00%
EPS (TTM)
$2.10
Revenue (TTM)
$1.07T
Return On Equity (TTM)
26.11%
Profit Margin
36.49%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-80.44%

ACADIA Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$283.99$268.06$307.96$342.29
Net Profit$273.57$3.64$31.50$53.52
Net Profit Margin96.33%1.36%10.23%15.64%
Income ChangeN/A-98.67%765.38%69.90%

ACADIA Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$517.24$726.44$957.80$1071.51
Net Profit-$215.98-$61.29$226.45$391.00
Net Profit Margin-41.76%-8.44%23.64%36.49%
Income ChangeN/A71.62%469.47%72.67%

ACADIA Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets502.08249.44132.8374.95
Current Assets1062.11938.32616.13512.86
Total Assets1564.21187.76748.96587.81
Non Current Liabilities59.6960.0962.9561.77
Current Liabilities277.11394.87254.25125.63
Total Liabilities336.81454.96317.2187.4
Shareholders' Equity1227.39732.79431.76400.41

ACADIA Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating109.84157.7216.7-114.04
Investing-302.56-30.5432.073.24
Financing49.886.8525.138.2

About ACADIA

Acadia Pharmaceuticals Inc is a biopharmaceutical company focused on turning scientific promise into making a difference for underserved neurological and rare disease communities around the world. It has two franchises in neurological and rare diseases. Its neurological disease franchise is anchored by the commercial product NUPLAZID (pimavanserin), which is the first and only drug approved by the U.S. FDA for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis (PDP). Its rare disease is anchored by the commercial product DAYBUE, which is the first and only drug approved for the treatment of Rett syndrome. Its clinical-stage development efforts are focused on Alzheimer's disease psychosis, Lewy Body Dementia psychosis, and multiple other programs.

ACADIA Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$20.70
$17.09
-16.92%
Oct 2026
$19.99
$20.57
+2.01%
Sep 2026
$29.25
$20.16
-32.18%
Aug 2026
$25.98
$29.73
+14.81%
Jul 2026
$25.32
$25.89
+2.27%
Jun 2026
$21.16
$25.32
+16.87%
May 2026
$22.22
$21.66
-3.48%
Apr 2026
$22.26
$22.44
+0.72%
Mar 2026
$23.93
$22.28
-9.23%
Feb 2026
$25.11
$24.55
-2.29%
Jan 2026
$26.72
$25.12
-5.88%
Dec 2025
$24.78
$26.69
+6.67%

ACADIA Share Price FAQs